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Undoubtedly, we are living in a period of great challenge
for the field of medical science. The COVID-19 epidemic is
an emerging and rapidly evolving situation that has brought
up scientific concepts that were no longer relevant. For a
long period of time, we did not experience situations that
had such a high mortality rate affecting entire popula-
tions, or diseases that followed their natural courses with
little prospect of treatment or reversal of their clinical
presentation.
Though we are accustomed to the concept of scientific
evidence that is preferably based on large clinical trials that
take years to complete, we must now rely on case studies,
single cohort studies, and even the opinions of experts.
However, we know that we cannot lose sight of the criteria
for evidence-based medicine, and must remember to eva-
luate all potential biases existing in this type of scientific
information without limiting its dissemination. Each piece
of information always has some value, by proposing new
hypotheses, expanding the debate, and evolving into new
quality scientific research.
With regard to the current situation, nearly 2,000 papers
with reference to COVID-19 have been registered in the
PubMed database since the beginning of 2020. They include
laboratory studies, clinical reports, guidelines, editorials with
experts’ opinions, and several observational studies. These
studies show initial observational evidence regarding possi-
ble pharmacological treatments or the use of prolonged
respiratory support methods as means of avoiding mortality,
morbidity, or even to decrease some secondary outcomes,
such as the viral load. Several potential COVID-19 treat-
ments have been described, including drugs already in use
for HIV and malaria, experimental compounds that work
against an array of viruses in animal experiments, and
antibody-rich plasma from people who have recovered from
the disease. Other studies are dedicated to identifying groups
at risk and the various factors involved—even moving
toward the proposition of scores that determine the best
allocation of resources and clinical interventions according to
the actual status of the patients. From these data, we can also
observe the rapid response of the international scientific
community through the proposal and initiation of rando-
mized multicenter clinical studies that will quickly determine
the real prospect of the use of several types of treatment.
Besides all of these efforts, the development of anti-viral
vaccines is connecting several groups around the world,
representing a necessary development for the prevention and
ultimate eradication of COVID-19.
This new situation requires scientific journals to ensure the
rapid publication of existing information, but at the same
time to ensure its quality and identify the potential biases
and limitations of the published data. As a task force of great
relevance, scientific editors must filter through the existing
material, while not failing to rely on the peer review process,
and must immediately deliver a response to the authors and
provide resources for the publication of data. In this regard,
the benefits of open access publications are obvious, espe-
cially for research in which urgency and speed are so
important. Unfortunately, the proportion of new scientific
research being published in open access journals is dis-
appointingly small. However, considering the urgency pre-
sented by the COVID-19 epidemic, there are some interesting
initiatives to increase the openness of research, data, and
publications. Nevertheless, we still see that only 30% of the
articles related to this disease provide full text accessibility in
the PubMed database.
The CLINICS journal, as an official publication of the Hos-
pital das Clínicas da Faculdade de Medicina da Universidade
de São Paulo (HC-FMUSP), now has the mission of expan-
ding the scientific literature on all aspects of COVID-19. As a
general and open access medical journal with an editorial
board and reviewers of high scientific qualifications, that is
committed to the importance and necessity of research on the
current situation, CLINICS is in a prominent position of great
responsibility.
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